| Effect of right ventricular function and venous congestion on cardiorenal interactions during the treatment of decompensated heart failure. | |
| | |
MedLine Citation:
|
PMID: 20152246 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recent reports have demonstrated the adverse effects of venous congestion on renal function (RF) and challenged the assumption that worsening RF is driven by decreased cardiac output (CO). We hypothesized that diuresis in patients with right ventricular (RV) dysfunction, despite decreased CO, would lead to a decrease in venous congestion and resultant improvement in RF. We reviewed consecutive admissions with a discharge diagnosis of heart failure. RV function was assessed by multiple echocardiographic methods and those with >or=2 measurements of RV dysfunction were considered to have significant RV dysfunction. Worsening RF was defined as an increase in creatinine of >or=0.3 mg/dl and improved RF as improvement in glomerular filtration rate >or=25%. A total of 141 admissions met eligibility criteria; 34% developed worsening RF. Venous congestion was more common in those with RV dysfunction (odds ratio [OR] 3.3, p = 0.009). All measurements of RV dysfunction excluding RV dilation correlated with CO (p <0.05). Significant RV dysfunction predicted a lower incidence of worsening RF (OR 0.21, p <0.001) and a higher incidence of improved RF (OR 6.4, p <0.001). CO emerged as a significant predictor of change in glomerular filtration rate during hospitalization in those without significant RV dysfunction (r = 0.38, p <0.001). In conclusion, RV dysfunction is a strong predictor of improved renal outcomes in patients with acute decompensated heart failure, an effect likely mediated by relief of venous congestion. |
| | |
Authors:
|
Jeffrey M Testani; Amit V Khera; Martin G St John Sutton; Martin G Keane; Susan E Wiegers; Richard P Shannon; James N Kirkpatrick |
Related Documents
:
|
11391036 - The endoventricular circular patch plasty ("dor procedure") in ischemic akinetic dilate... 6838206 - Cardiac carnitine deficiency and altered carnitine transport in cardiomyopathic hamsters. 3092616 - Acute intravenous and long-term oral hemodynamic effects of encainide. 11828136 - Successful weaning from milrinone of a patient with severe congestive heart failure usi... 19648586 - Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart... 1512336 - Improved myocardial ischemic response and enhanced collateral circulation with long rep... |
Publication Detail:
|
Type: Journal Article Date: 2010-01-05 |
Journal Detail:
|
Title: The American journal of cardiology Volume: 105 ISSN: 1879-1913 ISO Abbreviation: Am. J. Cardiol. Publication Date: 2010 Feb |
Date Detail:
|
Created Date: 2010-02-15 Completed Date: 2010-03-19 Revised Date: 2011-09-26 |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 511-6 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright 2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
Department of Medicine, Cardiovascular Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA. jeffrey.testani@uphs.upenn.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Biological Markers / blood Cardiac Output, Low / physiopathology Cohort Studies Creatinine / blood Diuretics / therapeutic use Female Glomerular Filtration Rate / drug effects Heart Failure / blood, complications, physiopathology*, therapy, ultrasonography Hospitals, University Humans Hyperemia / blood, physiopathology*, therapy, ultrasonography Incidence Kidney Diseases / complications, physiopathology*, therapy, ultrasonography Kidney Function Tests Length of Stay Male Middle Aged Natriuretic Peptide, Brain / blood Predictive Value of Tests Retrospective Studies Risk Assessment Risk Factors Severity of Illness Index Ventricular Dysfunction, Right / blood, physiopathology*, therapy, ultrasonography |
| Grant Support | |
ID/Acronym/Agency:
|
T32 HL007843-15/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Biological Markers; 0/Diuretics; 114471-18-0/Natriuretic Peptide, Brain; 60-27-5/Creatinine |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Thromboembolism in atrial fibrillation.
Next Document: Effects of Rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failu...